Elevance Health (ELV) Change in Receivables (2010 - 2026)

Elevance Health (ELV) has 17 years of Change in Receivables data on file, last reported at $657.0 million in Q2 2026.

• On a quarterly basis, Change in Receivables fell 28.82% year-over-year to $657.0 million in Q2 2026; TTM through Jun 2026 was $260.0 million, a 92.44% decrease from a year earlier, with the FY2025 full-year figure at $2.5 billion, up 269.84% from the prior year.
• Change in Receivables for Q2 2026 stood at $657.0 million, down from $1.2 billion in the prior quarter.
• Over the last five years, Change in Receivables for ELV reached as high as $3.2 billion in Q1 2025 and fell as low as -$851.0 million in Q3 2024.
• Historically, Change in Receivables has averaged $517.3 million across 5 years, with a median of $355.0 million in 2023.
• Across the five-year window, Change in Receivables jumped 2575.0% in 2023 and slumped 491.71% in 2025, its largest moves.
• Year by year, Change in Receivables stood at $1.8 billion in 2022, then slumped by 43.5% to $1.0 billion in 2023, then slumped by 81.35% to $193.0 million in 2024, then slumped by 491.71% to -$756.0 million in 2025, then soared by 186.9% to $657.0 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $657.0 million in Q2 2026, $1.2 billion in Q1 2026, and -$756.0 million in Q4 2025.